Goldberg Joshua E DO is categorized under Internal Medicine Doctors in Reading, PA and active since 2010.
Goldberg Joshua E DO was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Joshua Goldberg at the company’s single location by writing to 1 Granite Point Drive # 300, Reading, Pennsylvania PA 19610 or by phoning (610) 376-9728. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Goldberg Joshua E DO |
Contact Person: | Joshua Goldberg |
Address: | 1 Granite Point Drive # 300, Reading, Pennsylvania 19610 |
Phone Number: | (610) 376-9728 |
Website Address: | berksent.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Goldberg Joshua E DO was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Joshua Goldberg for inquiries that concern Goldberg Joshua E DO by calling the company number (610) 376-9728, as your correspondence is most welcome. Additionally, the physical location of the single location of Goldberg Joshua E DO can be found at the coordinates 40.33517,-75.96645 as well as the street address 1 Granite Point Drive # 300 in Reading, Pennsylvania 19610.
For its online presence, you may visit Goldberg Joshua E DO’s website at berksent.com and engage with its social media outlets through on Twitter and on Facebook.